Galapagos NV
GLPG
#4563
Rank
โ‚น189.74 B
Marketcap
โ‚น2,838
Share price
-0.57%
Change (1 day)
24.16%
Change (1 year)

Galapagos NV (GLPG) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น370.26 Billion

According to Galapagos NV's latest financial reports the company's total assets are โ‚น370.26 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Galapagos NV - Total assets on balance sheet (from 2008 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น369.19 B-7.93%
2023-12-31โ‚น401.00 B-4.58%
2022-12-31โ‚น420.23 B-4%
2021-12-31โ‚น437.74 B-14.89%
2020-12-31โ‚น514.33 B6.09%
2019-12-31โ‚น484.78 B321.02%
2018-12-31โ‚น115.14 B16.85%
2017-12-31โ‚น98.54 B27.26%
2016-12-31โ‚น77.43 B140.83%
2015-12-31โ‚น32.15 B54.23%
2014-12-31โ‚น20.84 B-14.97%
2013-12-31โ‚น24.51 B43.85%
2012-12-31โ‚น17.04 B54.04%
2011-12-31โ‚น11.06 B-4.29%
2010-12-31โ‚น11.56 B21.01%
2009-12-31โ‚น9.55 B19.65%
2008-12-31โ‚น7.98 B-6.31%
2007-12-31โ‚น8.52 B-13.02%
2006-12-31โ‚น9.79 B125.34%
2005-12-31โ‚น4.34 B374.03%
2004-12-31โ‚น0.91 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AstraZeneca
AZN
โ‚น10.282 T 2,677.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น17.321 T 4,578.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น13.684 T 3,595.81%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น12.028 T 3,148.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
โ‚น14.36 B-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น7.562 T 1,942.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น3.580 T 867.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น7.407 T 1,900.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น11.637 T 3,043.15%๐Ÿ‡บ๐Ÿ‡ธ USA